Leaflet OXITOCINA PANPHARMA 5UI / ml solution for injection / infusion

Indicated for: uterine contractions; postpartum hemorrhage

Route of administration: injectable / infusion

Substance: oxytocin (uterotonic)

ATC: H01BB02 (Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Oxytocin and analogues)

Oxytocin is a hormone used in obstetrics to induce labor, stimulate uterine contractions, or control postpartum hemorrhage. It works by stimulating oxytocin receptors in the uterus, causing muscle contractions.

The medication is administered intravenously or intramuscularly, as directed by a doctor, usually in doses adjusted based on the patient's response. It is important for administration to be performed under strict medical supervision.

Patients should be aware of potential side effects, such as nausea, vomiting, or uterine hypertonia. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, vomiting, and uterine hypertonia. In rare cases, severe reactions such as uterine rupture or allergic reactions may occur. Patients should be informed of these risks before use.

General data about OXITOCINA PANPHARMA 5UI / ml

  • Substance: oxytocin
  • Date of latest medicines list: 01-06-2026
  • Product code: W65329003
  • Concentration: 5UI / ml
  • Pharmaceutical form: solution for injection / infusion
  • Quantity: 10
  • Product type: Generic medicine
  • Price: 70.68 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: ROTEXMEDICA GMBH - GERMANIA
  • Holder: PANPHARMA - FRANTA
  • Number: 10479/2018/03
  • Shelf life: 3 years-after packaging for sale;dupa diluare-it is used immediately

Concentrations available for oxytocin

  • 16.7mcg/ml
  • 1UI/ml
  • 5UI/ml
  • 8.3mcg/ml